Breast Cancer Hormone Receptor Status Determination from H&E-Stained Biopsy Images Using Pixel-Level Classifiers
Authors:
Open Access
Abstract
Background: Analysis of digital images of histopathological sections is increasing due to widespread adoption of fully digitised workflows and the greater availability of whole-slide scanners. Currently, hormone receptor status in breast carcinoma is assessed by pathologists scoring separate immunohistochemically stained sections. Methods: In this study, we employed pathologist-verified pixel-level annotations to train nested pixel classifiers capable of making case-level predictions of oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status directly from H&E-stained sections using biopsy cases alone. The model was evaluated on both an internal test set and an external international evaluation set from an institution in a different continent using different scanner hardware without the need for image normalisation. Results: In the internal test set, the models achieved AUCs of 0.8030, 0.7956 and 0.7488 for ER, PR, and HER2, respectively, with AUCs of 0.7008 and 0.7488 for ER and PR using an external cohort from an institution from which no cases were used for training. Conclusions: Our data highlight a potential strategy by which a pixel-based classifier, typically developed to quantify histological features within individual cases, could be used to make case/slide-level predictions but illustrate the challenges associated with this approach.Keywords
Funding Information
- Medical Research Scotland (PHD-50538-2022)
This publication has 41 references indexed in Scilit:
- Application of artificial intelligence and digital tools in cancer pathologyThe Lancet Digital Health, 2025
- Inter‐rater agreement of HER2 ‐low scores between expert breast pathologists and the Visiopharm digital image analysis application ( HER2 APP , CE2797 )The Journal of Pathology: Clinical Research, 2025
- Deep learning-based classification of breast cancer molecular subtypes from H&E whole-slide imagesJournal of Pathology Informatics, 2024
- AI ‐guided histopathology predicts brain metastasis in lung cancer patientsThe Journal of Pathology, 2024
- Stain normalization methods for histopathology image analysis: A comprehensive review and experimental comparisonInformation Fusion, 2023
- Current and future burden of breast cancer: Global statistics for 2020 and 2040The Breast, 2022
- Pan-cancer integrative histology-genomic analysis via multimodal deep learningCancer Cell, 2022
- ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancerAnnals of Oncology, 2021
- Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast CancerJAMA Network Open, 2019
- Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast CancerJAMA, 2017